Colorectal Cancer Clinical Roundup

News Articles

Aspirin Reduces Long-term Colorectal Cancer Risk In Genetically Predisposed Individuals

(University of Jyväskylä [Finland]) June 12, 2020 - Aspirin reduces colorectal cancer risk by half in individuals at high genetic risk. Preventive efficacy is prolonged for 10-20 years after treatment with aspirin.

Clinical Challenges: Molecular Testing in CRC

(MedPage Today) June 8, 2020 - Consensus on testing for dMMR/MSI-H, but strategies vary for other biomarkers.

How a Delay in Colonoscopy Screening May Affect Cancer Risk

(New York Times) June 2, 2020 - For people at low risk for colon cancer, delays in colonoscopy screening may not dramatically affect cancer risk, a new study suggests. Current guidelines recommend a colonoscopy starting at age 45 to 50, and then one every 10 years afterward if the results are negative.

Blood Test Detects Colon Cancer in Single-Center Study

(Medscape Medical News) June 1, 2020 - A blood test detected 11 of 11 cases of colorectal cancer in a study involving 354 patients, and also spotted a majority of cases — 40 out of 53 — in which participants had advanced adenomas, an investigator said.

View all colorectal cancer news

Publications

The DNA Damage Response pathway as a land of therapeutic opportunities for colorectal cancer.

(Ann Oncol) - 2020-06-05

Increased Risk of Colorectal Cancer Tied to Advanced Colorectal Polyps: An Untapped Opportunity to Screen First-Degree Relatives and Decrease Cancer Burden.

(Am J Gastroenterol) - 2020-06-03

Treatment of Stage IV Colon Cancer in the United States: A Patterns-of-Care Analysis.

(J Natl Compr Canc Netw) - 2020-06-01

PD-1 Inhibitor Bests Chemo for Colorectal Cancer.

(Cancer Discov) - 2020-06-01

Podcasts

Colon and Rectal Cancer – David Ilson, MD, and Robert Figlin, MD, discuss recent clinical advances in colon and rectal cancer from ASCO20 Virtual

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center, and David Ilson, MD, Attending Physician, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College, discuss the progress in colon and rectal cancer presented at ASCO20

Colorectal Cancer – Jeffrey Meyerhardt, MD, and Robert Figlin, MD, discuss recent clinical advances in CRC from ASCO20 Virtual

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center, and Jeffrey A. Meyerhardt, Professor, Medicine, Harvard Medical School, Active Medical Staff, Medical Oncology, Dana-Farber Cancer Institute, discuss the progress in CRC presented at ASCO20

Featured Colorectal Cancer Tweets

Cathy Eng, MD
CathyEngMD - Jun 14 We @VUMC_Cancer are allowing one family member for our #cancer #patients for inpatient and in #clinic. The visitor… https://t.co/mQyVcjGABM

Howard S. Hochster, MD, FACP
HH_Oncodr - Jun 02 Major progress for MSI high #coloncancer. But some questions still exist!! Trials available @RutgersCancer https://t.co/onXeiCnZ4v

Axel F. Grothey, MD
agrothey - May 31 I have to say, what a GREAT year for GI ONC @ #ASCO20 - amazing, practice changing data all around. KN177, IDEA, re… https://t.co/IMr6ixDr7B